Form FDA 483 · Issued 2025-12-18
Invitro Research Solutions Private Ltd — FDA Form 483 Analysis
FEI: 3014372507 · Sector: Pharmaceuticals & Sterile/OTC Drugs (Control Testing Laboratory) · Lead Investigator: Elena R. Rostova
FDA Form 483 issued to Invitro Research Solutions Private Ltd (FEI 3014372507) on 2025-12-18 following an inspection of its control testing laboratory operations in India. The report documents 3 inspection observations centered on CAPA, Out-of-Specification (OOS) & Complaint Investigations, Personnel GMP Training, Gowning & Hygienic Practices.
Get Full Annotated 483 Dossier + CAPA Checklist
Instant PDF + CFR Matrix ($79 vs. Redica's $289)
Need Help Fixing These 3 Citations?
Get matched with a vetted 21 CFR remediation consultant
Observation-by-Observation 21 CFR Breakdown (3)
Observation #1 · 21 CFR 211.188(b)(12)
CAPA, Out-of-Specification (OOS) & Complaint Investigations
FIRST-TIME OBSERVATION
Investigations made into any unexplained discrepancy
Inspector Observation Language: "Batch production and control records do not include the results of any investigation made into any unexplained discrepancy, whether or not the batch of drug product had already been distributed. Specifically, observed during inspection of Invitro Research Solutions Private Ltd on 2025-12-18."
Plain-English Meaning: Failure to thoroughly investigate unexplained batch discrepancies, Out-of-Specification lab results, or consumer complaints/adverse events and document root-cause Corrective and Preventive Actions (CAPA).
Standard CAPA Remediation Path: Deploy a closed-loop CAPA and OOS investigation SOP requiring root-cause determination within 30 business days, impact assessment on distributed lots, and effectiveness checks.
Observation #2 · 21 CFR 212.10
Personnel GMP Training, Gowning & Hygienic Practices
FIRST-TIME OBSERVATION
Lack Adequate Resources, Facilities, Equipment.
Inspector Observation Language: "You lack adequate [resources] [facilities] [equipment] to enable your personnel to perform their functions. Specifically, observed during inspection of Invitro Research Solutions Private Ltd on 2025-12-18."
Plain-English Meaning: Operators performing manufacturing or QA tasks without documented GMP/SOP training, or observed gowning/hygiene deviations in production rooms.
Standard CAPA Remediation Path: Maintain role-based SOP training matrices signed prior to independent floor assignment and annual cGMP refresher assessments.
Observation #3 · 21 CFR 212.60(e)
CAPA, Out-of-Specification (OOS) & Complaint Investigations
REPEAT CITATION AT FACILITY
Equipment
Inspector Observation Language: "All equipment used to perform the testing is not [suitable for its intended purposes] [capable of producing valid results]. Specifically,observed during inspection of Invitro Research Solutions Private Ltd on 2025-12-18."
Plain-English Meaning: Failure to thoroughly investigate unexplained batch discrepancies, Out-of-Specification lab results, or consumer complaints/adverse events and document root-cause Corrective and Preventive Actions (CAPA).
Standard CAPA Remediation Path: Deploy a closed-loop CAPA and OOS investigation SOP requiring root-cause determination within 30 business days, impact assessment on distributed lots, and effectiveness checks.